Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.20.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues:    
Revenues $ 6,698,615 $ 6,750,351
Operating expenses:    
Cost of product sales 300,199  
Cost of product sales   (566,523)
Research and development 32,192,335 11,764,133
Acquired in-process research and development 25,549,344 0
General and administrative 17,417,450 10,123,320
Sales and marketing 2,341,231 1,484,044
Amortization expense 1,741,083 1,338,996
Change in fair value of contingent consideration 0 (1,256,211)
Total operating expenses 79,541,642 22,887,759
Loss from continuing operations (72,843,027) (16,137,408)
Other income:    
Change in fair value of Investment in Aytu 5,207,789 53,932
Other income (expense), net 409,853 (28,287)
Interest income, net 48,873 121,326
Total other income, net from continuing operations 5,666,515 146,971
Loss from continuing operations before taxes (67,176,512) (15,990,437)
Income tax (benefit) expense (2,792,961) 280,316
Loss from continuing operations (64,383,551) (16,270,753)
Income from discontinued operations, net of tax 883,779 198,206
Net loss (63,499,772) (16,072,547)
Product revenue, net    
Revenues:    
Revenues 6,698,615 6,650,351
License and other revenue    
Revenues:    
Revenues $ 0 $ 100,000
Common stock    
Net (loss) income per share of common stock, basic and diluted:    
Continuing operations (in dollars per share) $ (0.87) $ (0.28)
Discontinued operations (in dollars per share) 0.01 0.00
Net loss per share, basic and diluted (in dollars per share) (0.86) (0.28)
Preferred Stock    
Net (loss) income per share of common stock, basic and diluted:    
Continuing operations (in dollars per share) (4.38) (1.42)
Discontinued operations (in dollars per share) 0.06 0.01
Net loss per share, basic and diluted (in dollars per share) $ (4.32) $ (1.41)